Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 786,873 |
|
|||||
| News | - | ||||||
| Day High | 1.37 | Low High |
|||||
| Day Low | 1.29 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.03 | -2.22% | 1.32 | 19:46:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.36 | 1.29 | 1.37 | 1.33 | 1.35 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,712 | 786,873 | $ 1.32 | $ 1,040,964 | - | 0.4986 - 1.914 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:39:47 | formt | 100 | $ 1.32 | USD |
SELLAS Life Sciences Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42M | 32.06M | - | 0 | -37.34M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SELLAS Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.53 | 1.545 | 1.12 | 1.28 | 3,297,426 | -0.21 | -13.73% |
| 1 Month | 1.30 | 1.72 | 1.12 | 1.38 | 1,790,705 | 0.02 | 1.54% |
| 3 Months | 0.81 | 1.72 | 0.657 | 1.21 | 1,582,195 | 0.51 | 62.96% |
| 6 Months | 0.95 | 1.72 | 0.4986 | 1.03 | 1,295,523 | 0.37 | 38.95% |
| 1 Year | 1.48 | 1.914 | 0.4986 | 1.09 | 773,711 | -0.16 | -10.81% |
| 3 Years | 7.88 | 15.0789 | 0.4986 | 3.07 | 451,179 | -6.56 | -83.25% |
| 5 Years | 0.99 | 19.38 | 0.11 | 1.97 | 2,414,156 | 0.33 | 33.33% |
SELLAS Life Sciences Description
| SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |
